Divestment28 Apr 2026, 04:30 pm
Nectar Lifesciences Extends Slump Sale Completion to July 31, 2026
AI Summary
Nectar Lifesciences Ltd has announced an update regarding the previously disclosed slump sale of its business. The company and the purchaser, Capnest Health Care Private Limited, have mutually agreed to extend the completion date for this slump sale. The new expected completion date is now on or before July 31, 2026. All other relevant disclosures pertaining to the slump sale, as initially provided in the December 20, 2025 letter, remain unchanged.
Key Highlights
- Nectar Lifesciences extended its business slump sale deadline.
- New completion date is set for on or before July 31, 2026.
- The purchaser for the slump sale is Capnest Health Care Private Limited.
- All other terms and disclosures of the original slump sale remain unchanged.
Price Impact
More from NECLIFE